ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

NCI, NCAB o Seek $1.036 billion In ’79; Senate Committee Approves $920 Million for Fiscal ‘78

June 3, 1977

NCCF, Ad Council plan public service ads on childhood cancer.

November 7, 2003

Science Policy: Silicone Breast Implants Don’t Cause Disease

June 25, 1999

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

NCI-Approved Protocols Listed

December 26, 2003